Pharma Industry Outlook and Executive Insights at DCAT Week: Online Registration Closes March 15
Online registration for DCAT Week’s education programs closes Wednesday, March 15. Be sure to register in order to get executive insights and the latest market intelligence about the bio/pharma industry’s most pressing issues. Programs have built-in networking opportunities. Be seen and gain answers to these crucial questions from these must-attend programs.
How will the industry perform in 2023 and in the near term?
Monday, March 20, 2023: 2:30 – 4:30 PM; Doors open at 2:00 PM for networking & coffee. Plus, Post-Program Attendee Networking Reception: 4:30 to 6:00 PM.
Vice President,
Global Pharma Strategy, IQVIA
DCAT Week’s flagship program, Pharma Industry Outlook, provides you with need-to-know market intelligence on the current and projected performance of the bio/pharma industry. Graham Lewis, Vice President of Global Pharma Strategy, IQVIA, a business intelligence firm regarded as the gold standard for bio/pharmaceutical market analysis, will provide the latest market data and trends. Plus, get expert insight from Ernst & Young (EY) on the key trends in industry deal-making and capital flow into Emerging Pharma, a crucial customer base for CDMOs/CMOs and partner for bio/pharma companies.
Register or learn more about this program here.
How are can my company further address current market volatility and reduce supply risk?
Without question, dealing with recent market volatility (inflationary pressures, supply-chain disruptions, and geopolitical uncertainty) has been the number one issue facing the industry. These conditions have resulted in escalating raw materials costs, actual and potential supply risks, and pricing pressures. How is the industry addressing these issues now and in the long term?
DCAT is bringing in high-level executives to delve deeper and provide practical insights in how to best address these issues by giving multidimensional solution-based views for the industry.
Executive Insights: Weathering the Storm – The Path Forward in Optimizing Supply Practices
Tuesday, March 21, 2023: 10:30 – 11:45 AM; Doors open at 10:00 AM for coffee & networking.
Executive Vice President,
Global Product
Development & Supply,
Bristol-Myers Squibb
Senior executives from Bristol-Myers Squibb, Catalent, and BASF provide a “buy” and “sell”-side view on ways to optimize supply practices in light of recent market volatility: inflationary pressures, supply-chain disruptions, and geopolitical uncertainty. Learn from them on the following key questions.
- What are the new best practices and approaches in contracting?
- How has supplier evaluation and selection been affected?
- What are the risk-mitigation strategies needed now and how can we anticipate the ones that will be necessary in the future?
Register or learn more about the program here.
Industry Radar 2023: Energy, Raw Materials & Sustainability
Tuesday, March 21, 2023: 2:00 PM – 3:15 PM; Doors open at 1:30 PM for coffee & networking.
Senior Vice President,
Global Procurement and
Chief Procurement Officer, GlaxoSmithKline
The industry is facing two hot-button issues: input costs and sustainability. An energy and chemicals outlook examines the pressure points in raw materials and what can be expected in 2023. Plus, Lisa Martin, Chief Procurement Officer (CPO), GlaxoSmithKline (GSK), provides a CPO view on sustainability and how GSK is working with suppliers to meet sustainability targets.
Register or learn more about this program here.
The Disruption Busters: New Approaches in Supplier Risk Assessment & Mitigation
Wednesday, March 22, 2023: 10:15 AM – 11:30 AM; Due to an earlier program, doors open at 10:00 AM
As supply chains become more complex, extended, and globalized, companies are more and more dependent on their suppliers, making supplier selection, risk assessment and mitigation even more important and difficult.
How are other industries dealing with the unprecedented supply-chain challenges of today? The program will provide expert insight from the automotive, tech, and other industries on new approaches/tools in supplier risk assessment and mitigation to build greater supply-chain resiliency.
*This program is presented in partnership with the Axia Institute, a research and education center of Michigan State University (MSU) and part of MSU’s Office of Research and Innovation. DCAT is also partnered with MSU’s Broad College of Business and its top-ranked Supply Chain Management Program.
Register or learn more about this program here.
